- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Novo Nordisk invests $1.2bn to establish rare disease production facility in Denmark | ||
| Fr | Gilead's seladelpar recommended by CHMP to treat primary biliary cholangitis | ||
| Fr | Taking the campaign against cancer into the cloud | ||
| Fr | Shaping tomorrow with strategic foresight in early commercialisation | ||
| Fr | Brand strategy - reviewing what you've learnt | ||
| Do | Merck gains rights to Hansoh's preclinical GLP-1 candidate in deal worth $2bn | ||
| Do | Amgen's Blincyto granted MHRA approval for new acute lymphoblastic leukaemia indication | ||
| Do | FDA approves Organon's Vtama cream to treat atopic dermatitis in adults and children | ||
| Do | Rare vs common diseases: key differences in educational approaches | ||
| Do | Communicating AI in healthcare: a guide for effective strategy | ||
| Do | Big hats, no cattle | ||
| Mi | AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition | ||
| Mi | GSK's Jemperli receives positive CHMP opinion for expanded endometrial cancer use | ||
| Mi | Eli Lilly's Omvoh recommended by CHMP to treat Crohn's disease in adults | ||
| Mi | Is omnichannel right for rare diseases? | ||
| Mi | Creating a future with more clinical empathy | ||
| Di | Sanofi's tolebrutinib granted FDA breakthrough designation for MS | ||
| Di | CHMP recommends Galderma's nemolizumab for atopic dermatitis and prurigo nodularis | ||
| Di | The need for a human touch in an AI world | ||
| Di | Best practices in linguistic validation of clinical outcomes assessments | ||
| Mo | AbbVie's Parkinson's disease candidate tavapadon shows promise in phase 3 trial | ||
| Mo | Merck shares positive phase 3 results for Keytruda/Lynparza regimen in ovarian cancer | ||
| Mo | Tackling the growing burden of chronic obstructive pulmonary disease in the UK | ||
| Mo | Over 40 years of Ipsen in the UK: resilience and leadership in the life sciences sector | ||
| 13.12. | Eli Lilly announces $3bn expansion to US injectables manufacturing facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
